Interpace Biosciences Incの収益YQ/Q
Interpace Biosciences Incの収益YQ/Qは何ですか。
Interpace Biosciences Incの収益YQ/Qは10.86%です。
収益YQ/Qの定義は何ですか。
四半期収益成長率、前年比は、前年同期の業績と比較して、売上高の増加率がパーセンテージとして表されています。
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
NASDAQのセクタHealth Careにおける収益YQ/Qの企業と比べるInterpace Biosciences Inc
Interpace Biosciences Incは何をしますか。
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Interpace Biosciences Incと類似の収益yq/q
- Trilogiq SAの収益YQ/Qは10.84%です。
- Federal Signalの収益YQ/Qは10.85%です。
- Cairn PLCの収益YQ/Qは10.85%です。
- Banco Santander, S.Aの収益YQ/Qは10.85%です。
- Niraku GCの収益YQ/Qは10.85%です。
- Cairn Plcの収益YQ/Qは10.85%です。
- Interpace Biosciences Incの収益YQ/Qは10.86%です。
- Britvic Plcの収益YQ/Qは10.87%です。
- Enghouse Systemsの収益YQ/Qは10.88%です。
- Halma Plcの収益YQ/Qは10.88%です。
- Tata Consumer Productsの収益YQ/Qは10.88%です。
- Vizioの収益YQ/Qは10.88%です。
- Bausch Health Companies Incの収益YQ/Qは10.89%です。